Vireo Growth (VREOF) Net Cash Flow (2020 - 2026)
Vireo Growth (VREOF) posted Net Cash Flow of $15.3 million for Q1 2026, up 208.74% sequentially from $5.0 million in Q4 2025, and up 383.33% YoY from $3.2 million in Q1 2025.
Vireo Growth (VREOF) Net Cash Flow (2020 - 2026) Analysis & Trends
Vireo Growth has reported Net Cash Flow for 7 years, with the latest figure at $15.3 million in Q1 2026.
- Quarterly Net Cash Flow rose 383.33% year-over-year to $15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.6 million (down 29.91% YoY) and the FY2025 annual result came in at $30.9 million, down 59.16% from the prior year.
- Net Cash Flow advanced to $15.3 million in Q1 2026 per VREOF's latest filing, from $5.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $84.3 million in Q4 2024 and troughed at -$6.7 million in Q4 2022.
- A 5-year average of $7.2 million and a median of $2.0 million in 2023 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 3059.99% in 2024, down 302.53% in 2024.
- Over 5 years, Net Cash Flow stood at -$6.7 million in 2022, then jumped by 139.87% to $2.7 million in 2023, then jumped by 3059.99% to $84.3 million in 2024, then plunged by 94.12% to $5.0 million in 2025, then jumped by 208.74% to $15.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $15.3 million, $5.0 million, and $11.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Vireo Growth | 491.44 Mn | 349.14 Mn | 95.30 Mn | -15.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.30 Mn |
| Mar 31, 2026 | 15.30 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 11.35 Mn |
| Sep 30, 2025 | 11.35 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Dec 31, 2024 | 84.33 Mn |
| Dec 31, 2024 | 84.33 Mn |
| Sep 30, 2024 | -3.95 Mn |
| Sep 30, 2024 | -3.95 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Mar 31, 2024 | -3.36 Mn |
| Mar 31, 2024 | -3.36 Mn |
| Dec 31, 2023 | 2.67 Mn |
| Dec 31, 2023 | 2.67 Mn |